Safety of intraperitoneal 32% dextran 70 as an antiadhesion adjuvant.

J Reprod Med

Pope Paul VI Institute for the Study of Human Reproduction, Creighton University School of Medicine, Omaha, NE 68106.

Published: August 1989

The records of 139 consecutive patients who underwent major gynecologic abdominal surgery in which 32% dextran 70 was used as an antiadhesion adjuvant were carefully reviewed for the presence or absence of dextran-related complications. Eleven patients (8.0%) were thought to have dextran-related complications, including postoperative ileus (2.9%), pleural effusion (2.2%), allergic reactions (1.4%), wound infection (1.4%) and labial swelling (0.7%). The mean amount of dextran used was 183 mL. The study indicated that dextran can be used in moderate amounts when instilled intraperitoneally and has an acceptably low rate of complications. Since dextran is used often in spite of scanty evidence of its effectiveness as an antiadhesion adjuvant, understanding its safety and potential complications is especially important.

Download full-text PDF

Source

Publication Analysis

Top Keywords

antiadhesion adjuvant
12
32% dextran
8
dextran antiadhesion
8
dextran-related complications
8
dextran
5
safety intraperitoneal
4
intraperitoneal 32%
4
adjuvant records
4
records 139
4
139 consecutive
4

Similar Publications

Article Synopsis
  • * Anti-adhesive therapy aims to block bacteria from attaching to host cells, thereby preventing infections, and natural compounds from food sources show promise in this area.
  • * The review highlights several dietary components that have anti-adhesive properties against various harmful bacteria, suggesting potential for these agents as nutraceuticals or to enhance traditional antibiotic treatments.
View Article and Find Full Text PDF
Article Synopsis
  • Biofilms are microorganism clusters encased in a protective matrix, causing significant challenges in various sectors like food, healthcare, and marine industries due to their resilience against antibiotics and sanitizers.
  • Current methods for removing biofilms include chemical and mechanical techniques, but they often fall short against biofilm communities, highlighting the need for innovative solutions.
  • Biosurfactants, particularly sophorolipids, are promising "green" alternatives that offer improved biodegradability, reduced toxicity, and effective antiadhesive properties, making them valuable in tackling biofilm-related issues in healthcare.
View Article and Find Full Text PDF

The microbiota in the oral cavity has a strict connection to its host. Its imbalance may determine oral diseases and can also have an impact on the systemic health. Probiotic strains may help in the restoration of a balanced condition.

View Article and Find Full Text PDF

is a major human pathogen, able to establish difficult-to-treat infections in immunocompromised and people with cystic fibrosis (CF). The high rate of antibiotic treatment failure is due to its notorious drug resistance, often mediated by the formation of persistent biofilms. Alternative strategies, capable of overcoming resistance, include antivirulence compounds which impair bacterial pathogenesis without exerting a strong selective pressure, and the use of antimicrobial adjuvants that can resensitize drug-resistant bacteria to specific antibiotics.

View Article and Find Full Text PDF
Article Synopsis
  • Two international guidelines highlight various methods to prevent reformation of intrauterine adhesions (IUAs) after treating Asherman syndrome (AS), but their effectiveness varies.
  • This study reviews 29 articles, including randomized controlled trials and cohort studies, focusing on the effectiveness of different methods for secondary prevention of IUAs.
  • Key findings show that methods like second-look hysteroscopy and continuous intrauterine balloons significantly reduce the risk of adhesion reformation compared to control methods.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!